MabThera
The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.
| Name | MabThera |
|---|---|
| Active Substance | rituksimab |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| ATC Code | L01XC02 |
| Medicinal product marketed in the Croatia | Da |
| Summary of product characteristics (SmPC), labelling and package leaflet (PL) | download |
| Link to the European Medicines Agency's (EMA) product information | download |
| Link to the European Commission's (EC) decisions | download |
| Educational materials for healthcare professionals |
Vodič o izgledu, čuvanju, rukovanju i primjeni, verzija 2 Kartica usporedbe supkutane i intravenske primjene, verzija 2 Knjižica za zdravstvene radnike, verzija 6 |
| Educational materials for patients / caregivers |
Priručnik za bolesnike, verzija 5 Kartica za bolesnike |
